Cell Growth & Differentiation, Vol 6, Issue 12 1643-1650, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism

JR Gasdaska, M Berggren and G Powis
Arizona Cancer Center, University of Arizona, Tucson 85724, USA.

Thioredoxins are a class of low molecular weight redox proteins that undergo reversible reduction-oxidation of two active-site cysteine residues with reduction catalyzed by the NADPH-dependent flavoenzyme thioredoxin reductase. Human thioredoxin has been shown to be identical to a previously reported leukemic cell growth factor. We now report that recombinant human thioredoxin added to minimal culture medium in the absence of serum stimulates the proliferation of a number of human solid tumor cell lines measured over several days. The concentration of thioredoxin producing half-maximal stimulation of MCF-7 breast cancer cell proliferation was 350 nM, and the maximum stimulation occurred at 5 microM. The maximum increase in cell proliferation caused by thioredoxin was up to 90% of that seen with 10% bovine serum in the medium. There was a positive correlation between the ability of cell lines to proliferate in minimal medium, presumably, due to the autocrine production of growth factors by the cells, and the stimulation of proliferation by thioredoxin. Neither a redox inactive, mutant human thioredoxin, C32S/C35S, nor reduced Escherichia coli thioredoxin were able to stimulate MCF-7 cell proliferation. MCF-7 cell proliferation caused by human thioredoxin was completely abolished if the culture medium was changed each day. Antibody to thioredoxin blocked the cell proliferation caused by thioredoxin. Studies with 125I-labeled thioredoxin showed time-dependent binding to the surface of MCF-7 cells, but the binding was not saturable, indicating the absence of specific binding of thioredoxin to a cell surface receptor. Most of the thioredoxin associated with the cell could be released by trypsinization, and relatively little intact thioredoxin was taken up by the cell. The results of the study suggest that thioredoxin acts by a novel helper, redox mechanism to increase the cell proliferation response to growth factor(s) produced by the cell itself.

This article has been cited by other articles:

				T. Ebrahimian, M. R. Sairam, E. L. Schiffrin, and R. M. Touyz Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1481 - H1488. [Abstract] [Full Text] [PDF]

				W. Qiu, L. Wang, W. Lu, A. Boechler, D. A. R. Sanders, and D. Zhong Dissection of complex protein dynamics in human thioredoxin PNAS, March 27, 2007; 104(13): 5366 - 5371. [Abstract] [Full Text] [PDF]

				A. S. Georgiou, E. Sostaric, C. H. Wong, A. P. L. Snijders, P. C. Wright, H. D. Moore, and A. Fazeli Gametes Alter the Oviductal Secretory Proteome Mol. Cell. Proteomics, November 1, 2005; 4(11): 1785 - 1796. [Abstract] [Full Text] [PDF]

				N. Berteaux, S. Lottin, D. Monte, S. Pinte, B. Quatannens, J. Coll, H. Hondermarck, J.-J. Curgy, T. Dugimont, and E. Adriaenssens H19 mRNA-like Noncoding RNA Promotes Breast Cancer Cell Proliferation through Positive Control by E2F1 J. Biol. Chem., August 19, 2005; 280(33): 29625 - 29636. [Abstract] [Full Text] [PDF]

				Q. Shi, H.-L. Chen, H. Xu, and G. E. Gibson Reduction in the E2k Subunit of the {alpha}-Ketoglutarate Dehydrogenase Complex Has Effects Independent of Complex Activity J. Biol. Chem., March 25, 2005; 280(12): 10888 - 10896. [Abstract] [Full Text] [PDF]

				B. F. Jordan, M. Runquist, N. Raghunand, R. J. Gillies, W. R. Tate, G. Powis, and A. F. Baker The Thioredoxin-1 Inhibitor 1-Methylpropyl 2-Imidazolyl Disulfide (PX-12) Decreases Vascular Permeability in Tumor Xenografts Monitored by Dynamic Contrast Enhanced Magnetic Resonance Imaging Clin. Cancer Res., January 15, 2005; 11(2): 529 - 536. [Abstract] [Full Text] [PDF]

				S. S. Sheth, L. W. Castellani, S. Chari, C. Wagg, C. K. Thipphavong, J. S. Bodnar, P. Tontonoz, A. D. Attie, G. D. Lopaschuk, and A. J. Lusis Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition J. Lipid Res., January 1, 2005; 46(1): 123 - 134. [Abstract] [Full Text] [PDF]

				B. J. Deroo, S. C. Hewitt, S. D. Peddada, and K. S. Korach Estradiol Regulates the Thioredoxin Antioxidant System in the Mouse Uterus Endocrinology, December 1, 2004; 145(12): 5485 - 5492. [Abstract] [Full Text] [PDF]

				S. E Hardt and J. Sadoshima Negative regulators of cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 500 - 509. [Abstract] [Full Text] [PDF]

				H. Yamawaki, J. Haendeler, and B. C. Berk Thioredoxin: A Key Regulator of Cardiovascular Homeostasis Circ. Res., November 28, 2003; 93(11): 1029 - 1033. [Abstract] [Full Text] [PDF]

				S. Yegorova, A. Liu, and M. F. Lou Human Lens Thioredoxin: Molecular Cloning and Functional Characterization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3263 - 3271. [Abstract] [Full Text] [PDF]

				K. Kunchithapautham, B. Padmavathi, R. B. Narayanan, P. Kaliraj, and A. L. Scott Thioredoxin from Brugia malayi: Defining a 16-Kilodalton Class of Thioredoxins from Nematodes Infect. Immun., July 1, 2003; 71(7): 4119 - 4126. [Abstract] [Full Text] [PDF]

				M. Tanudji, S. Hevi, and S. L. Chuck The nonclassic secretion of thioredoxin is not sensitive to redox state Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1272 - C1279. [Abstract] [Full Text] [PDF]

				L. M. Butler, X. Zhou, W.-S. Xu, H. I. Scher, R. A. Rifkind, P. A. Marks, and V. M. Richon The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin PNAS, September 3, 2002; 99(18): 11700 - 11705. [Abstract] [Full Text] [PDF]

				S. J. Welsh, W. T. Bellamy, M. M. Briehl, and G. Powis The Redox Protein Thioredoxin-1 (Trx-1) Increases Hypoxia-inducible Factor 1{alpha} Protein Expression: Trx-1 Overexpression Results in Increased Vascular Endothelial Growth Factor Production and Enhanced Tumor Angiogenesis Cancer Res., September 1, 2002; 62(17): 5089 - 5095. [Abstract] [Full Text] [PDF]

				S. Lechner, U. Muller-Ladner, K. Schlottmann, B. Jung, M. McClelland, J. Ruschoff, J. Welsh, J. Scholmerich, and F. Kullmann Bile acids mimic oxidative stress induced upregulation of thioredoxin reductase in colon cancer cell lines Carcinogenesis, August 1, 2002; 23(8): 1281 - 1288. [Abstract] [Full Text] [PDF]

				A. Lopata, M.C. Sibson, A.C. Enders, K.L. Bloomfield, M.S. Gregory, G.D. Trapani, A.V. Perkins, K.F. Tonissen, and F.M. Clarke Expression and localization of thioredoxin during early implantation in the marmoset monkey Mol. Hum. Reprod., December 1, 2001; 7(12): 1159 - 1165. [Abstract] [Full Text] [PDF]

				L.-e. Shao, M. B. Diccianni, T. Tanaka, R. Gribi, A. L. Yu, J. D. Pullen, B. M. Camitta, and J. Yu Thioredoxin Expression in Primary T-Cell Acute Lymphoblastic Leukemia and Its Therapeutic Implication Cancer Res., October 1, 2001; 61(19): 7333 - 7338. [Abstract] [Full Text] [PDF]

				S. Kakolyris, A. Giatromanolaki, M. Koukourakis, G. Powis, J. Souglakos, E. Sivridis, V. Georgoulias, K. C. Gatter, and A. L. Harris Thioredoxin Expression Is Associated with Lymph Node Status and Prognosis in Early Operable Non-Small Cell Lung Cancer Clin. Cancer Res., October 1, 2001; 7(10): 3087 - 3091. [Abstract] [Full Text] [PDF]

				A. Vogt, K. Tamura, S. Watson, and J. S. Lazo Antitumor Imidazolyl Disulfide IV-2 Causes Irreversible G2/M Cell Cycle Arrest without Hyperphosphorylation of Cyclin-Dependent Kinase Cdk1 J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1070 - 1075. [Abstract] [Full Text]

				E. Junn, S. H. Han, J. Y. Im, Y. Yang, E. W. Cho, H. D. Um, D. K. Kim, K. W. Lee, P. L. Han, S. G. Rhee, et al. Vitamin D3 Up-Regulated Protein 1 Mediates Oxidative Stress Via Suppressing the Thioredoxin Function J. Immunol., June 15, 2000; 164(12): 6287 - 6295. [Abstract] [Full Text] [PDF]

				A. J. Freemerman, A. Gallegos, and G. Powis Nuclear Factor {{kappa}}B Transactivation Is Increased But Is Not Involved in the Proliferative Effects of Thioredoxin Overexpression in MCF-7 Breast Cancer Cells Cancer Res., August 1, 1999; 59(16): 4090 - 4094. [Abstract] [Full Text] [PDF]

				A. Nishiyama, M. Matsui, S. Iwata, K. Hirota, H. Masutani, H. Nakamura, Y. Takagi, H. Sono, Y. Gon, and J. Yodoi Identification of Thioredoxin-binding Protein-2/Vitamin D3 Up-regulated Protein 1 as a Negative Regulator of Thioredoxin Function and Expression J. Biol. Chem., July 30, 1999; 274(31): 21645 - 21650. [Abstract] [Full Text] [PDF]

				R. Bertini, O.M. Zack Howard, H.-F. Dong, J. J. Oppenheim, C. Bizzarri, R. Sergi, G. Caselli, S. Pagliei, B. Romines, J. A. Wilshire, et al. Thioredoxin, a Redox Enzyme Released in Infection and Inflammation, Is a Unique Chemoattractant for Neutrophils, Monocytes, and T Cells J. Exp. Med., June 7, 1999; 189(11): 1783 - 1789. [Abstract] [Full Text] [PDF]

				J. R. Pedrajas, E. Kosmidou, A. Miranda-Vizuete, J.-A. Gustafsson, A. P. H. Wright, and G. Spyrou Identification and Functional Characterization of a Novel Mitochondrial Thioredoxin System in Saccharomyces cerevisiae J. Biol. Chem., March 5, 1999; 274(10): 6366 - 6373. [Abstract] [Full Text] [PDF]

				T. Maruyama, Y. Sachi, K. Furuke, Y. Kitaoka, H. Kanzaki, Y. Yoshimura, and J. Yodoi Induction of Thioredoxin, a Redox-Active Protein, by Ovarian Steroid Hormones during Growth and Differentiation of Endometrial Stromal Cells in Vitro Endocrinology, January 1, 1999; 140(1): 365 - 372. [Abstract] [Full Text]

				S. Gromer, L. D. Arscott, C. H. Williams Jr., R. H. Schirmer, and K. Becker Human Placenta Thioredoxin Reductase. ISOLATION OF THE SELENOENZYME, STEADY STATE KINETICS, AND INHIBITION BY THERAPEUTIC GOLD COMPOUNDS J. Biol. Chem., August 7, 1998; 273(32): 20096 - 20101. [Abstract] [Full Text] [PDF]

				A. Miranda-Vizuete, A. E. Damdimopoulos, J.-A. Gustafsson, and G. Spyrou Cloning, Expression, and Characterization of a Novel Escherichia coli Thioredoxin J. Biol. Chem., December 5, 1997; 272(49): 30841 - 30847. [Abstract] [Full Text] [PDF]

				S. Leppa, L. Pirkkala, S. C. Chow, J. E. Eriksson, and L. Sistonen Thioredoxin Is Transcriptionally Induced upon Activation of Heat Shock Factor 2 J. Biol. Chem., November 28, 1997; 272(48): 30400 - 30404. [Abstract] [Full Text] [PDF]

				G. Spyrou, E. Enmark, A. Miranda-Vizuete, and J.-A. Gustafsson Cloning and Expression of a Novel Mammalian Thioredoxin J. Biol. Chem., January 31, 1997; 272(5): 2936 - 2941. [Abstract] [Full Text] [PDF]

				D. Daily, A. Vlamis-Gardikas, D. Offen, L. Mittelman, E. Melamed, A. Holmgren, and A. Barzilai Glutaredoxin Protects Cerebellar Granule Neurons from Dopamine-induced Apoptosis by Activating NF-kappa B via Ref-1 J. Biol. Chem., January 5, 2001; 276(2): 1335 - 1344. [Abstract] [Full Text] [PDF]

				D. Daily, A. Vlamis-Gardikas, D. Offen, L. Mittelman, E. Melamed, A. Holmgren, and A. Barzilai Glutaredoxin Protects Cerebellar Granule Neurons from Dopamine-induced Apoptosis by Dual Activation of the Ras-Phosphoinositide 3-Kinase and Jun N-terminal Kinase Pathways J. Biol. Chem., June 8, 2001; 276(24): 21618 - 21626. [Abstract] [Full Text] [PDF]